Compositions including a botanical extract and methods of using the same in skin whitening and skin lightening applications
AssigneeAccess Business Group International LLC
InventorsJatinder Rana, Ganesh Diwakar, XiaoJuan Shen, Jeffrey Scholten, Rebecca Miller
Life of this patent
Estimating the term…
Abstract
Compositions for topical use and having a melanin synthesis-inhibiting activity that include an amount of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescentis, or Chrysanthemum morifolium effective to reduce melanin synthesis are described. Methods for inhibiting melanin synthesis and for skin whitening are also described.
Claims9
A method of whitening skin comprising topically applying to the skin a composition comprising at least 50% w/w of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescens, and Chrysanthemum morifolium standardized to about 0.5-50% luteolin-7 glucoside, wherein the composition is applied in an amount and for a period of time sufficient to visibly whiten the skin.
A method of visibly whitening human skin comprising topically applying to the skin an effective amount of botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescens, and Chrysanthemum morifolium, standardized to about 0.5-50% luteolin-7 glucoside in an amount and for a period of time sufficient to visibly whiten the skin.
A method for inhibiting melanin synthesis comprising topically applying to the skin a composition comprising at least 50% w/w of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescens, and Chrysanthemum morifolium standardized to about 0.5-50% luteolin-7 glucoside and effective to reduce melanin synthesis, wherein the composition is applied in an amount and for a period of time sufficient to inhibit melanin synthesis in the skin.
A method for treating or preventing cholasma comprising topically applying to the skin of a subject a composition comprising at least 50% w/w of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescens, and Chrysanthemum morifolium standardized to about 0.5-50% luteolin-7 glucoside and effective to treat or prevent cholasma, wherein the composition is applied in an amount and for a period of time sufficient to treat or prevent cholasma in the skin of the subject.
Dependencies are inferred from the claim text.